Hawaii SB482 mandates cognitive assessments for Medicare beneficiaries aged 65 and older during annual wellness visits.
Hawaii SB482 aims to improve the detection and treatment of Alzheimer's disease and related dementias by mandating cognitive assessments for Medicare beneficiaries aged 65 and older during annual wellness visits. Health care providers must conduct these assessments using standardized, validated tools approved by the Food and Drug Administration and covered by Medicare. Patients may decline the assessment after being informed of its purpose, benefits, and risks.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.